Balance Sheet Breakdown: Colgate-Palmolive Co (CL)’s Debt-to-Equity and Long-Term Debt/Eq Ratios

In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.

After finishing at $80.04 in the prior trading day, Colgate-Palmolive Co (NYSE: CL) closed at $80.39, up 0.44%. In other words, the price has increased by $0.44 from its previous closing price. On the day, 2.57 million shares were traded. CL stock price reached its highest trading level at $80.44 during the session, while it also had its lowest trading level at $79.91.

Ratios:

Our goal is to gain a better understanding of CL by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 44.02 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 18.82. For the most recent quarter (mrq), Quick Ratio is recorded 0.60 and its Current Ratio is at 0.93. In the meantime, Its Debt-to-Equity ratio is 9.84 whereas as Long-Term Debt/Eq ratio is at 8.54.

On October 28, 2024, Stifel Downgraded its rating to Hold which previously was Buy and also lowered its target price recommendation from $105 to $101. On September 24, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $121.Piper Sandler initiated its Overweight rating on September 24, 2024, with a $121 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 21 ’25 when Massey Sally sold 1,237 shares for $80.89 per share. The transaction valued at 100,061 led to the insider holds 13,751 shares of the business.

Massey Sally sold 2,250 shares of CL for $200,183 on May 15 ’25. The Chief Human Resources Officer now owns 12,583 shares after completing the transaction at $88.97 per share. On Feb 25 ’25, another insider, Massey Sally, who serves as the Chief Human Resources Officer of the company, sold 8,000 shares for $92.02 each. As a result, the insider received 736,152 and left with 14,805 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CL now has a Market Capitalization of 64972869632 and an Enterprise Value of 72128561152. As of this moment, Colgate-Palmolive’s Price-to-Earnings (P/E) ratio for their current fiscal year is 22.53, and their Forward P/E ratio for the next fiscal year is 20.94. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 5.06. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.22 while its Price-to-Book (P/B) ratio in mrq is 75.70. Its current Enterprise Value per Revenue stands at 3.589 whereas that against EBITDA is 14.989.

Stock Price History:

The Beta on a monthly basis for CL is 0.29, which has changed by -0.17217588 over the last 52 weeks, in comparison to a change of 0.1326145 over the same period for the S&P500. Over the past 52 weeks, CL has reached a high of $100.18, while it has fallen to a 52-week low of $74.54. The 50-Day Moving Average of the stock is 2.31%, while the 200-Day Moving Average is calculated to be -7.16%.

Shares Statistics:

The stock has traded on average 6.32M shares per day over the past 3-months and 5653410 shares per day over the last 10 days, according to various share statistics. A total of 806.06M shares are outstanding, with a floating share count of 804.88M. Insiders hold about 0.15% of the company’s shares, while institutions hold 86.01% stake in the company. Shares short for CL as of 1763078400 were 14262439 with a Short Ratio of 2.26, compared to 1760486400 on 15401100. Therefore, it implies a Short% of Shares Outstanding of 14262439 and a Short% of Float of 1.97.

Dividends & Splits

In the trailing 12 months, CL’s forward annual dividend rate was 2.04, compared to 2.06 this year. Against a Trailing Annual Dividend Yield of 0.025487255. The stock’s 5-year Average Dividend Yield is 2.3. . The current Payout Ratio is 56.42% for CL, which recently paid a dividend on 2025-10-17 with an ex-dividend date of 2025-10-17. Stock splits for the company last occurred on 2013-05-16 when the company split stock in a 2:1 ratio.

Earnings Estimates

Its stock is currently analyzed by 16.0 different market analysts. The consensus estimate for the next quarter is $0.95, with high estimates of $1.0 and low estimates of $0.9.

Analysts are recommending an EPS of between $3.7 and $3.61 for the fiscal current year, implying an average EPS of $3.66. EPS for the following year is $3.84, with 19.0 analysts recommending between $3.97 and $3.75.

Revenue Estimates

13 analysts predict $5.13B in revenue for . The current quarter. It ranges from a high estimate of $5.23B to a low estimate of $5.02B. As of . The current estimate, Colgate-Palmolive Co’s year-ago sales were $4.94BFor the next quarter, 13 analysts are estimating revenue of $5.15B. There is a high estimate of $5.24B for the next quarter, whereas the lowest estimate is $5B.

A total of 18 analysts have provided revenue estimates for CL’s current fiscal year. The highest revenue estimate was $20.43B, while the lowest revenue estimate was $19.98B, resulting in an average revenue estimate of $20.28B. In the same quarter a year ago, actual revenue was $20.1BBased on 18 analysts’ estimates, the company’s revenue will be $20.98B in the next fiscal year. The high estimate is $21.28B and the low estimate is $20.61B.